Posts Tagged ‘Hepatitis C’


House Appropriations Committee passes FY2018 health services budget bill that offers no additional funding for HIV or viral hepatitis initiatives; does not acknowledge the rising rates of Hepatitis C infections in the U.S.

By | Leave a Comment

In a vote that followed party lines, the House Appropriations Committee passed the FY2018 Health and Human Services, Education, and Related Agencies Appropriations bill on July 20, 2017. The bill rejects most of the proposed cuts to health services recommended by the current Administration, but does little to boost funding for health services that desperately […]

Read More

Posted in Health reform, National Healthcare, Uncategorized; Tagged: , , .


Louisiana Proposes that the Federal Government Bypass Patent Restrictions to Acquire Cheaper Hepatitis C Drugs

By | Leave a Comment

Anyone who follows U.S. public health issues – or who reads my blog posts – knows that the cost of the drugs needed to treat Hepatitis C infections is very high. The cost of these drugs is of particular concern to state health authorities who are charged with providing health care for Medicaid recipients and […]

Read More

Posted in FDA, National Healthcare, Uncategorized; Tagged: .


Obama signs $6.3 billion Cures Act – But Does it Do More Harm than Good?

By | Leave a Comment

On December 13th, President Obama signed the 21st Century Cures Act into law. This law provides $6.3 billion for cancer cure research, and to address the growing opioid drug abuse epidemic. The Act also allows for a more streamlined approval process for the FDA to bring new drugs and medical devices to the market. While […]

Read More

Posted in FDA, Health reform, Uncategorized; Tagged: , .


Now What?? The Potential Effects of a Trump Administration and Republican-Controlled Congress on Hepatitis C care

By | Leave a Comment

The 2016 presidential election ended in a result that few who are passionate about public health, human rights, and race, gender and sexual orientation equality could have ever wanted. However, as we face the reality of this reality, we who work to improve health outcomes must steel our resolve and continue to address the critical […]

Read More

Posted in Health reform, National Healthcare; Tagged: , .


O’Neill Institute Hosts Meeting to discuss improving Hepatitis C data collection and surveillance

By | Leave a Comment

On September 19th, the Hepatitis C Policy Project hosted a meeting at the Georgetown University Law Center in Washington, DC to discuss strategies to improve data collection and case surveillance for Hepatitis C in the United States. Thought leaders from a range of public health backgrounds, – including physicians, patient advocates, researchers and federal agency directors […]

Read More

Posted in National Healthcare, Uncategorized; Tagged: , .


Archives

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.